Artiva Biotherapeutics, Inc. (ARTV) stock
ARTVNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$3.77−0.09 (-2.33%)
Close on Nov 18, 2026Market cap $184.32MP/E –Yield –
Artiva Biotherapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Artiva Biotherapeutics's market cap was $115.13M on Nov 11, 2026, against $68.14M a year earlier.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $115.13M | +325.0% |
| 2025 | Jan 31, 2025 | $27.09M | -49.6% |
| 2024 | Dec 31, 2024 | $53.74M | – |
See a number that looks wrong?